{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:56:09Z","timestamp":1793382969985,"version":"4.5.0"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The impact of glucocorticoids, comorbid conditions, and immunosuppressive therapies on Pneumocystis jirovecii pneumonia risk remains understudied, and prophylaxis is underused. Among US adults in TriNetX prescribed glucocorticoids for \u22652 weeks, 44.6% received &amp;gt;20\u2005mg prednisone equivalents daily. Prophylaxis rates were low, with higher glucocorticoid doses associated with lower prophylaxis odds.<\/jats:p>","DOI":"10.1093\/cid\/ciaf147","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T21:06:41Z","timestamp":1742677601000},"page":"1015-1018","source":"Crossref","is-referenced-by-count":6,"title":["Glucocorticoids, Concomitant Immunosuppression, and\n                    <i>Pneumocystis jirovecii<\/i>\n                    Pneumonia Prophylaxis Among US Adults"],"prefix":"10.1093","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4018-0195","authenticated-orcid":false,"given":"Daniel B","family":"Chastain","sequence":"first","affiliation":[{"name":"Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy , Albany, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8518-5750","authenticated-orcid":false,"given":"George R","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of California, Davis Medical Center , Sacramento, California ,","place":["USA"]},{"name":"Department of Medical Microbiology and Immunology, University of California, Davis Medical Center , Sacramento, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7363-8652","authenticated-orcid":false,"given":"Andr\u00e9s F","family":"Henao-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of Colorado Anschutz Medical Campus , Aurora, Colorado ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"2025122403225541500_ciaf147-B1","doi-asserted-by":"crossref","first-page":"e214920","DOI":"10.1001\/jamanetworkopen.2021.4920","article-title":"Prevalence of immunosuppressive drug use among commercially insured US adults, 2018\u20132019","volume":"4","author":"Wallace","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2025122403225541500_ciaf147-B2","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1093\/cid\/ciad474","article-title":"Unintended consequences: risk of opportunistic infections associated with long-term glucocorticoid therapies in adults","volume":"78","author":"Chastain","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025122403225541500_ciaf147-B3","doi-asserted-by":"crossref","first-page":"100400","DOI":"10.1016\/j.lanepe.2022.100400","article-title":"Evolving epidemiology of pneumocystis pneumonia: findings from a longitudinal population-based study and a retrospective multi-center study in Germany","volume":"18","author":"Kolbrink","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"2025122403225541500_ciaf147-B4","doi-asserted-by":"crossref","first-page":"ooad035","DOI":"10.1093\/jamiaopen\/ooad035","article-title":"A global federated real-world data and analytics platform for research","volume":"6","author":"Palchuk","year":"2023","journal-title":"JAMIA Open"},{"key":"2025122403225541500_ciaf147-B5","author":"TriNetX"},{"key":"2025122403225541500_ciaf147-B6","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/ard-2022-223335","article-title":"2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases","volume":"82","author":"Fragoulis","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025122403225541500_ciaf147-B7","doi-asserted-by":"crossref","first-page":"e13587","DOI":"10.1111\/ctr.13587","article-title":"Pneumocystis jiroveci in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Fishman","year":"2019","journal-title":"Clin Transplant"},{"key":"2025122403225541500_ciaf147-B8","doi-asserted-by":"crossref","first-page":"ofz315","DOI":"10.1093\/ofid\/ofz315","article-title":"Practice patterns of pneumocystis pneumonia prophylaxis in connective tissue diseases: a survey of infectious disease physicians","volume":"6","author":"Wolfe","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2025122403225541500_ciaf147-B9","author":"National Comprehensive Cancer Network"},{"key":"2025122403225541500_ciaf147-B10","volume-title":"Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV","author":"Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV"},{"key":"2025122403225541500_ciaf147-B11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12281-024-00482-8","article-title":"Pneumocystis jirovecii pneumonia in HIV-negative, non-transplant patients: epidemiology, clinical manifestations, diagnosis, treatment, and prevention","volume":"18","author":"Rhoads","year":"2024","journal-title":"Curr Fungal Infect Rep"},{"issue":"15 suppl","key":"2025122403225541500_ciaf147-B12","doi-asserted-by":"crossref","first-page":"e12022","DOI":"10.1200\/JCO.2019.37.15_suppl.e12022","article-title":"Relation between dexamethasone (DEX) usage, preventive trimetprim\/sulfametoxazole (ST), and pneumocystis pneumonia (PCP) for patients with breast cancer receiving dose-dense AC followed by dose-dense paclitaxel (ddAC-ddP): preplanned analysis of WJOG9016B","volume":"37","author":"Matsumoto","year":"2019","journal-title":"J Clin Oncol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf147\/62521259\/ciaf147.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/5\/1015\/62521259\/ciaf147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/5\/1015\/62521259\/ciaf147.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T08:23:04Z","timestamp":1766564584000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/81\/5\/1015\/8090137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":12,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3,21]]},"published-print":{"date-parts":[[2025,12,24]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf147","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11,15]]},"published":{"date-parts":[[2025,3,21]]}}}